Literature DB >> 25213721

Validation of a severity grading score (SGS) system for predicting the course of disease and mortality in patients with Crimean-Congo hemorrhagic fever (CCHF).

M Bakır1, M G Gözel, I Köksal, Z Aşık, Ö Günal, H Yılmaz, A But, G Yılmaz, A Engin.   

Abstract

We aimed to validate a severity grading score (SGS) system for predicting the course of disease and fatality in Crimean-Congo hemorrhagic fever (CCHF). This SGS was established using several variables that were assumed to be associated with mortality and had clinical importance. We included patients diagnosed with CCHF from different centers. Patients who had symptoms of CCHF for <5 days were included. The patients were grouped into three categories according to mortality risk. An SGS ≤4 showed no association with mortality [n = 323 (79.9 % of the total study population), and all survived]. An SGS between 5 and 8 points was classified into the intermediate risk group (20 %), and 14 of 70 patients in this group died. An SGS ≥9 was classified as the high risk of mortality group and 11 of 11 patients in this group died (p = 0.001). The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for an SGS >9 points at admission were 96, 100, 97, 100, and 44 %, respectively. This SGS system may help appropriate the triage of patients, decrease the cost of treatment, and improve the functionality of healthcare staff. The present study is the first investigation about the validation of an SGS system in patients with CCHF.

Entities:  

Mesh:

Year:  2014        PMID: 25213721     DOI: 10.1007/s10096-014-2238-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

1.  The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.

Authors:  Gurdal Yilmaz; Iftihar Koksal; Murat Topbas; Hulya Yilmaz; Firdevs Aksoy
Journal:  J Clin Virol       Date:  2010-02-09       Impact factor: 3.168

Review 2.  Crimean-Congo hemorrhagic fever: current and future prospects of vaccines and therapies.

Authors:  Maryam Keshtkar-Jahromi; Jens H Kuhn; Iva Christova; Steven B Bradfute; Peter B Jahrling; Sina Bavari
Journal:  Antiviral Res       Date:  2011-03-06       Impact factor: 5.970

3.  Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited.

Authors:  O Ergonul; A Celikbas; N Baykam; S Eren; B Dokuzoguz
Journal:  Clin Microbiol Infect       Date:  2006-06       Impact factor: 8.067

Review 4.  Crimean-Congo hemorrhagic fever.

Authors:  Chris A Whitehouse
Journal:  Antiviral Res       Date:  2004-12       Impact factor: 5.970

5.  The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.

Authors:  Iftihar Koksal; Gurdal Yilmaz; Firdevs Aksoy; Hava Aydin; Ilknur Yavuz; Serap Iskender; Korhan Akcay; Sukru Erensoy; Rahmet Caylan; Kemalettin Aydin
Journal:  J Clin Virol       Date:  2009-12-03       Impact factor: 3.168

6.  Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever.

Authors:  Nuriye Tasdelen Fisgin; Esra Tanyel; Levent Doganci; Necla Tulek
Journal:  Trop Doct       Date:  2009-07       Impact factor: 0.731

7.  Severity scoring index for Crimean-Congo hemorrhagic fever and the impact of ribavirin and corticosteroids on fatality.

Authors:  Basak Dokuzoguz; Aysel Kocagül Celikbas; Şebnem Eren Gök; Nurcan Baykam; Mustafa Necati Eroglu; Önder Ergönül
Journal:  Clin Infect Dis       Date:  2013-08-14       Impact factor: 9.079

8.  Evaluation of clinical and laboratory predictors of fatality in patients with Crimean-Congo haemorrhagic fever in a tertiary care hospital in Turkey.

Authors:  Cigdem Ataman Hatipoglu; Cemal Bulut; Meltem Arzu Yetkin; Gunay Tuncer Ertem; Fatma Sebnem Erdinc; Esra Kaya Kilic; Tugba Sari; Sami Kinikli; Behic Oral; Ali Pekcan Demiroz
Journal:  Scand J Infect Dis       Date:  2010-07

9.  Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients.

Authors:  Roman Wölfel; Janusz T Paweska; Nadine Petersen; Antoinette A Grobbelaar; Patricia A Leman; Roger Hewson; Marie-Claude Georges-Courbot; Anna Papa; Stephan Günther; Christian Drosten
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

Review 10.  Crimean-Congo haemorrhagic fever.

Authors:  Onder Ergönül
Journal:  Lancet Infect Dis       Date:  2006-04       Impact factor: 25.071

View more
  10 in total

1.  Is the brain spared in Crimean-Congo haemorrhagic fever? An MR-SWI study to reveal CNS involvement.

Authors:  Bilge Öztoprak; İbrahim Öztoprak; Aynur Engin
Journal:  Eur Radiol       Date:  2018-03-12       Impact factor: 5.315

2.  Which scoring system is effective in predicting mortality in patients with Crimean Congo hemorrhagic fever? A validation study.

Authors:  Mehmet Bakir; Caner Öksüz; Faruk Karakeçili; Nurcan Baykam; Şener Barut; Seyit Ali Büyüktuna; Zülal Özkurt; Murteza Öz; Orçun Barkay; Özlem Akdoğan; Nazif Elaldi; Murşit Hasbek; Aynur Engin
Journal:  Pathog Glob Health       Date:  2021-12-06       Impact factor: 3.735

3.  Direct healthcare costs for patients hospitalized with Crimean-Congo haemorrhagic fever can be predicted by a clinical illness severity scoring system.

Authors:  Ilkay Bozkurt; Mustafa Sunbul; Hava Yilmaz; Saban Esen; Hakan Leblebicioglu; Nicholas J Beeching
Journal:  Pathog Glob Health       Date:  2016-02-25       Impact factor: 2.894

4.  Association Between Severity Grading Score And Acute Phase Reactants In Patients With Crimean Congo Hemorrhagic Fever.

Authors:  Ilkay Bozkurt; Saban Esen
Journal:  Pathog Glob Health       Date:  2021-01-23       Impact factor: 2.894

5.  Apoptosis-Related Gene Expression in an Adult Cohort with Crimean-Congo Hemorrhagic Fever.

Authors:  Nil Guler; Cafer Eroglu; Hava Yilmaz; Adil Karadag; Hasan Alacam; Mustafa Sunbul; Tom E Fletcher; Hakan Leblebicioglu
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

6.  Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman.

Authors:  Seif S Al-Abri; Roger Hewson; Hanan Al-Kindi; Idris Al-Abaidani; Amina Al-Jardani; Amal Al-Maani; Samira Almahrouqi; Barry Atkinson; Adil Al-Wahaibi; Bader Al-Rawahi; Shyam Bawikar; Nicholas J Beeching
Journal:  PLoS Negl Trop Dis       Date:  2019-04-25

7.  The pulmonary findings of Crimean-Congo hemorrhagic fever patients with chest X-ray assessments.

Authors:  Fatma Aktaş; Turan Aktaş
Journal:  Radiol Med       Date:  2019-03-25       Impact factor: 3.469

8.  Rotational thromboelastometry alongside conventional coagulation testing in patients with Crimean-Congo haemorrhagic fever: an observational cohort study.

Authors:  Tom E Fletcher; Hakan Leblebicioglu; Ilkay Bozkurt; Mustafa Sunbul; Heval Bilek; Zahide Asik; Sener Barut; Ferdi Gunes; Umit Gemici; Roger Hewson; Duncan Wilson; Matt K O'Shea; Tom Woolley; Brian Faragher; Kiran Parmar; David G Lalloo; Nick J Beeching; Beverley J Hunt
Journal:  Lancet Infect Dis       Date:  2019-06-28       Impact factor: 71.421

9.  Treatment of Cryptococcal Meningitis: How Have We Got Here and Where are We Going?

Authors:  Nguyen Thi Thuy Ngan; Barnaby Flower; Jeremy N Day
Journal:  Drugs       Date:  2022-09-16       Impact factor: 11.431

10.  Evaluation of Prognostic Values of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Crimean-Congo Hemorrhagic Fever Patients.

Authors:  Yunus Gurbuz; Baris Ozturk; Emin Ediz Tutuncu; Irfan Sencan; Gonul Cicek Senturk; Fatma Aybala Altay
Journal:  Jundishapur J Microbiol       Date:  2015-10-20       Impact factor: 0.747

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.